Physician profile
Amit Bhusri
NPI 1548302821
$908.77
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $83.99 · 2021: $122 · 2022: $273 · 2023: $224 · 2024: $24.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $248.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $245.34 | 2022-2024 | Botox |
| Fidia Pharma USA INC. | $148.34 | 2019-2023 | Triluron, Hymovis |
| Merz North America, INC. | $111.35 | 2019-2020 | |
| Pacira Therapeutics, INC. | $106.40 | 2019-2021 | |
| Lundbeck LLC | $94.74 | 2022-2023 | Vyepti |
| Medtronic, INC. | $48.89 | 2021-2022 | |
| Merz Pharmaceuticals, LLC | $36.39 | 2021 | |
| Bioventus LLC | $31.18 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $19.71 | 2023 | Zilretta, Iovera |
| Biogen, INC. | $17.11 | 2019 | |
| Impel Pharmaceuticals INC. | $17.11 | 2023 | Trudhesa |
| Medline Industries LP | $16.39 | 2023 | |
| Depuy Synthes Sales INC. | $15.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Bhusri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.